Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Antioxidants (Basel, Switzerland)|May 18, 2017
The Interplay between Oncogenic Signaling Networks and Mitochondrial DynamicsSarbajeet Nagdas, David F Kashatus
Current Oncology (Toronto, Ont.)|August 28, 2024
Deciphering the FGFR2 Code: Innovative Targets in Gastric Cancer TherapyAlireza Tojjari, Sarbajeet Nagdas, Ali Saeed, et al.
The Journal of Biological Chemistry|June 5, 2012
Headless Myo10 is a negative regulator of full-length Myo10 and inhibits axon outgrowth in cortical neuronsAlexander N Raines, Sarbajeet Nagdas, Michael L Kerber, et al.
ACS Applied Materials & Interfaces|July 10, 2014
Cell division orientation on biospecific peptide gradientsBrian M Lamb, Wei Luo, Sarbajeet Nagdas, et al.
Biomolecules|July 29, 2025
PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic CancerXiaolong Wei, William J Kane, Sara J Adair, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 12, 2020
miR-206 family is important for mitochondrial and muscle function, but not essential for myogenesis in vitroRoza K Przanowska, Ewelina Sobierajska, Zhangli Su, et al.
Cell Reports|August 15, 2019
Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor GrowthSarbajeet Nagdas, Jennifer A Kashatus, Aldo Nascimento, et al.
Journal of Surgical Oncology|July 17, 2024
Survival benefit associated with screening of patients at elevated risk for pancreatic cancerWilliam J Kane, Kathleen R Haden, Elizabeth N Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2017
CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic CancerAlex D Michaels, Timothy E Newhook, Sara J Adair, et al.
Pageof 2